Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2020-05-04 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1356 characters) and is explicitly labeled as an 'RNS Number'. It announces a 'Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a specific, non-standard regulatory announcement that does not fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (AGM-R, DVA). Since it is a general regulatory announcement provided by RNS, the most appropriate classification is the general regulatory fallback category.
2020-05-04 English
COVID-19 Antigen Test Collaboration with Adeptrix
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 5768L' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates a regulatory news service announcement. The content is a press release announcing a new collaboration regarding COVID-19 antigen testing, which is a material business update. Since it is a general regulatory announcement disseminated via the RNS system and does not fit neatly into specific categories like 10-K, ER, or DIV, the most appropriate classification is the general regulatory filing category.
2020-05-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly identified as an 'RNS Number' notification from 'Avacta Group PLC' dated '27 April 2020'. The form title is 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. The presence of the RNS header and the specific content detailing voting rights changes confirm this classification. Therefore, the appropriate code is MRQ.
2020-04-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document explicitly starts with 'RNS Number' and mentions 'Avacta Group PLC' and the date. The form title is 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership that cross regulatory thresholds. This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing about share ownership changes, making MRQ the most precise classification over the general RNS fallback.
2020-04-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number : 8714K' and contains a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing about share ownership changes, making MRQ the most precise classification. The document details the percentage of voting rights held by Unicorn Asset Management Limited and Unicorn AIM VCT plc.
2020-04-24 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1375 characters) and contains an 'RNS Number' (8645K) and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or CAP). Since it is a general regulatory announcement provided via the RNS service that doesn't fit into the more specific categories (like DIRS, MANG, or DIV), the most appropriate classification is the general regulatory fallback category.
2020-04-24 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.